308-nm Excimer laser treatment of palmoplantar psoriasis
- 14 March 2011
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Cosmetic and Laser Therapy
- Vol. 13 (2), 47-49
- https://doi.org/10.3109/14764172.2011.564769
Abstract
Psoriasis is a chronic inflammatory condition affecting 1-3% of the population. The incidence of palmoplantar involvement has been estimated to be between 2.8% and 40.9%. Significant psychosocial distress and difficulty performing activities of daily living can result. Treatment is often challenging. Traditional treatments include topical steroids, anthralin, calcipotriene, PUVA, methotrexate, cyclosporine, retinoids and biologics. In this case series, we report our success with the 308-nm excimer laser in the treatment of palmoplantar psoriasis.Keywords
This publication has 7 references indexed in Scilit:
- Palmoplantar psoriasis: A phenotypical and clinical review with introduction of a new quality-of-life assessment toolJournal of the American Academy of Dermatology, 2009
- A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patientsJournal of the European Academy of Dermatology and Venereology, 2009
- 308-nm excimer laser in psoriasis vulgaris, scalp psoriasis, and palmoplantar psoriasisJournal of the European Academy of Dermatology and Venereology, 2009
- A 308-nm monochromatic excimer light in the treatment of palmoplantar psoriasisJournal of the European Academy of Dermatology and Venereology, 2006
- Treatment of palmoplantar psoriasis with monochromatic excimer light (308-nm) versus cream PUVAActa Dermato-Venereologica, 2006
- 308-nm Excimer Laser for the Treatment of PsoriasisArchives of Dermatology, 2000
- 308 nm UVB excimer laser for psoriasisThe Lancet, 1997